For the Inventor, By the Inventor

Enter assignee name

Alameda, CA, United States of America

Avigen, Inc.

USPTO Granted Patents = 31

% Expired Patents = 6.5

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 1,070

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Peter C Colosi (14 out of 21 patents)

Gary J Kurtzman (12 out of 20 patents)

Gregory M Podsakoff (5 out of 12 patents)

4. Georges Natsoulis (4 out of 5 patents)

5. Paul D Kessler (3 out of 10 patents)

6. Barry J Byrne (3 out of 8 patents)

7. Kirk William Johnson (3 out of 36 patents)

8. Hideho Okada (2 out of 13 patents)

9. Federico C A Gaeta (2 out of 24 patents)

10. Hema S Sista (2 out of 5 patents)

11. Yero J Espinoza (2 out of 5 patents)

12. Matthew I Gross (2 out of 3 patents)

13. Xiaobing Qian (2 out of 3 patents)

14. Jun Yoshida (2 out of 3 patents)

15. Linda B Couto (2 out of 2 patents)

Core Competencies:

Gene Therapy

Adeno-Associated Virus

Recombinant AAV

CNS Disorders

Neuropathic Pain

Solid Tumors

Pharmaceutical Formulations

Nucleotide Sequence Delivery

Immune Response Induction

Factor VIII Expression

High-Efficiency AAV

Virion Production

31 patents: Sort by Forward Citations

1. 7622256 - Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1 (2009-11-24),

2. 7585875 - Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use (2009-09-08),

3. 7534806 - Method for treating neuropathic pain and associated syndromes (2009-05-19),

4. 7037713 - High-efficiency wild-type-free AAV helper functions (2006-05-02),

5. 6953575 - Methods of treating central nervous system disorders using viral vectors (2005-10-11),

6. 6897063 - Accessory functions for use in recombinant AAV virion production (2005-05-24),

7. 6764845 - Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith (2004-07-20),

8. 6759050 - Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith (2004-07-06),

9. 6593123 - Large-scale recombinant adeno-associated virus (rAAV) production and purification (2003-07-15),

10. 6531456 - Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors (2003-03-11),

11. 6482633 - Accessory functions for use in recombinant AAV virion production (2002-11-19),

12. 6416992 - Compositions and methods for producing recombinant adeno-associated virus (2002-07-09),

13. 6391858 - Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors (2002-05-21),

14. 6376237 - High-efficiency wild-type-free AAV helper functions (2002-04-23),

15. 6365403 - High-efficiency AAV helper functions (2002-04-02),

Avigen, Inc. is a biotechnology company based in Alameda, California, specializing in the development of innovative gene therapies. The company focuses on advancing treatments for neurological and genetic disorders, leveraging its expertise in gene delivery systems and therapeutic development. Avigen's research is aimed at addressing unmet medical needs through cutting-edge technologies, contributing to the evolving landscape of gene-based medicine. Its commitment to scientific excellence positions it as a key player in the biotechnology sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

31 Patents

#14 in Alameda, CA

#2,609 in California

#10,912 in US

#21,217 in the World

Alameda, CA, United States of America

Avigen, Inc.

Forward Citations = 1,070

30 inventors:

Peter C Colosi (14 out of 21 patents)

Gary J Kurtzman (12 out of 20 patents)

Gregory M Podsakoff (5 out of 12 patents)

4. Georges Natsoulis (4 out of 5 patents)

5. Paul D Kessler (3 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…